Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2011
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J05AE12
|
| gptkbp:CASNumber |
394730-60-0
|
| gptkbp:developedBy |
gptkb:Merck_&_Co.
|
| gptkbp:discontinued |
yes
|
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:genericName |
gptkb:boceprevir
|
| gptkbp:hasMolecularFormula |
C27H45N5O5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Victrelis
|
| gptkbp:indication |
gptkb:chronic_hepatitis_C_genotype_1
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
NS3/4A protease inhibitor
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
nausea fatigue dysgeusia |
| gptkbp:usedFor |
gptkb:hepatitis_C
|
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|